USPTO serial 79375787
Reviewed by CopyMark Law Group
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
R. Peter Spies
R. Peter Spies DTL, Ltd160 N. Wacker DriveSuite 500Chicago, IL 60606| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Arrays of filtering microwells for the analysis of complex bio-molecules for medical use in human or veterinary medicine; biological preparations for medical use for diagnostics of cardiovascular diseases, in oncology, inflammatory, autoimmune and infectious diseases; chemical preparations for medical use for diagnostics of cardiovascular diseases, in oncology, inflammatory, autoimmune and infectious diseases; pharmaceutical preparations for analysis, diagnosis and prognosis, namely, treatment of cardiovascular diseases, in oncology or inflammatory diseases; chemical reagents for medical and pharmacological use; diagnostic biomarker reagents for medical use and conducting pharmacology studies | ACTIVE | — |
| 010 | Medical apparatus for analysis, diagnosis and prognosis for medical use for treatment of cardiovascular diseases, for use in oncology, for use infectiology or inflammatory diseases in human or veterinary medicine; medical apparatus for analysis, diagnosis and prognosis, namely, treatment of cardiovascular diseases; analysis, diagnosis and prognosis devices for medical use and medical research; medical devices for analysis, diagnosis and prognosis of cardiovascular diseases; medical devices, namely, analytical devices for medical use in biomarker identification; portable analysis devices for in vitro diagnosis for medical use or medical research or medicine production; clinical chemistry analyzers of complex bio-molecules and autoimmune and inflammatory-related biomarkers for medical use; medical device in the nature of analysis device for medical use based on miniaturized immunological technology for treatment of cardiovascular diseases, infectious diseases, oncology, autoimmune diseases or inflammatory diseases. | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 8, 2025 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Feb 14, 2025 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Feb 14, 2025 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jan 17, 2025 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jan 2, 2025 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jan 1, 2025 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Nov 28, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Aug 27, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Aug 27, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 11, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 11, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 22, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 4, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 4, 2024 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| May 4, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 4, 2024 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| May 4, 2024 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| May 4, 2024 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| May 4, 2024 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 6, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 4, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 4, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 27, 2024 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 4, 2024 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 4, 2024 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Feb 9, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Feb 8, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 31, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 15, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 11, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 4, 2023 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |